SA

Shrihari Anil Nahulikar

Active Director Director DIN 10727833
DIN 10727833 First appointment Aug 2024 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Shrihari Anil Nahulikar

Data last updated:

Shrihari Anil Nahulikar is a Director at Xfusion Pharmaceutical Private Limited (since 2024). The company operates in Pharma.

DIN 10727833
Primary Designation Director
Industry Pharma
First Appointment 01 Aug 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director01 Aug 20242024Active

Board colleagues of Shrihari Anil Nahulikar

NameDINCompanyDesignation
Kiran Trimbak Naik10727834Xfusion Pharmaceutical Private LimitedDirector

Directorship timeline

Open interactive timeline →
Xfusion Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Shrihari Anil Nahulikar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shrihari Anil Nahulikar

Shrihari Anil Nahulikar currently holds 1 directorship: Xfusion Pharmaceutical Private Limited (Director, since 01 Aug 2024).

Shrihari Anil Nahulikar was first appointed on 01 Aug 2024 as Director at Xfusion Pharmaceutical Private Limited.

The current boards of Shrihari Anil Nahulikar's companies include Kiran Trimbak Naik (Xfusion Pharmaceutical Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available